HSKA - ヘスカ (Heska Corporation) ヘスカ

 HSKAのチャート


 HSKAの企業情報

symbol HSKA
会社名 Heska Corp. (ヘスカ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Biological Products (No Diagnostic Substances)  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 ヘスカ(Heska Corporation)は獣医向けの診断と特殊製品の販売に従事する会社。同社はコアコンパニオンアニマルヘルス(CCA)とその他のワクチン、医薬品と製品(OVP)事業という2つの事業セグメントを運営する。CCA事業セグメントは、主に犬と猫に使用される血液検査機器と消耗品、デジタル画像製品、ソフトウェアとサービス、ローカルとクラウドベースのデータサービス、アレルギー検査と免疫療法、並びに病院内診断テストとワーム予防製品などの単回使用製品を含む。OVP事業セグメントは、牛用、並びに馬、ブタ、鳥類、猫及び犬を含む他の種の動物向けの個人ラベルワクチンと薬品を含む。すべてのOVP製品はサードパーティのラベルの下で第三者によって販売される。同社は、犬や猫のヘルスケア分野における獣医師へのサポートを中心とする。同社は、獣医向けの血液検査と他の器具のラインを提供し、他の動物健康会社向けの生物学的製剤と医薬品を生産する。   ヘスカは米国の獣医製品メ―カ―。動物向けに医薬品ヘルスケア製品の開発、製造、販売、サポ―トを行う。犬・猫などのペット動物を対象に血液検査機器、フィラリア診断テスト、フィラリア予防製品、アレルギ―免疫療法製品、アレルギ―検査、およびデジタル画像製品を提供する。また、牛や小型哺乳類を含む他の動物向けにワクチンや医薬品を提供する。   Heska Corporation manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.
本社所在地 3760 Rocky Mountain Avenue Loveland CO 80538 USA
代表者氏名 Sharon J. Larson シャロンJ.ラーソン
代表者役職名 Independent Chairman of the Board
電話番号 +1 970-493-7272
設立年月日 1988年
市場名 NASDAQ Small Cap
ipoyear 1997年
従業員数 345人
url www.heska.com
nasdaq_url https://www.nasdaq.com/symbol/hska
adr_tso
EBITDA EBITDA(百万ドル) 19.84200
終値(lastsale) 97.06
時価総額(marketcap) 727735594.46
時価総額 時価総額(百万ドル) 751.87850
売上高 売上高(百万ドル) 127.05000
企業価値(EV) 企業価値(EV)(百万ドル) 744.22250
当期純利益 当期純利益(百万ドル) 11.96300
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Heska Corp revenues decreased 1% to $62.4M. Net income decreased 49% to $4.1M. Revenues reflect Other Vaccines Pharmaceuticals_Products segment decrease of 32% to $9M. Net income also reflects Other Vaccines Pharmaceuticals_Products segment loss totaling $712K vs. income of $3.7M. Basic Earnings per Share excluding Extraordinary Items decreased from $1.13 to $0.57.

 HSKAのテクニカル分析


 HSKAのニュース

   Veterinary Healthcare 2022 Global Market Outlook, Research, Trends and Forecast to 2028  2022/05/26 12:49:00 SBWire
Global Veterinary Healthcare Market is valued approximately USD 49119.8 Million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.31% over the forecast period 2022-2028. London, UK -- ( SBWIRE ) -- 05/26/2022 -- A New Market Research Study on "Global Veterinary Healthcare Size & Growth Analysis Report 2022-2028" added on intelligencemarketreport.com with the latest market size, share, trends and regional analysis. Veterinary Healthcare offers treatment for both small and large animals with experienced and professional vet services. The major factors driving the growth for the market are increasing prevalence of zoonotic diseases. For instance, according to the World Health Organization (WHO), there are currently over 200 prevailing zoonosis diseases around the world, including new and existing diseases, as of 2020. According to a UN Food and Agriculture Organization report, the majority of human diseases are spread by animals. Along with this, increasing initiatives by governments and animal welfare associations globally.
   Veterinary Diagnostic Equipment Global Market Report 2022  2022/05/26 10:23:00 GlobeNewswire
Major players in the Veterinary diagnostic equipment market are IDEXX Laboratories, ABAXIS, HESKA Corporation, Zoetis, Virbac, Mindray Medical International Ltd. , Neogen Corporation, QIAGEN N. V. , Agfa Healthcare, and Toshiba. Major players in the Veterinary diagnostic equipment market are IDEXX Laboratories, ABAXIS, HESKA Corporation, Zoetis, Virbac, Mindray Medical International Ltd. , Neogen Corporation, QIAGEN N. V. , Agfa Healthcare, and Toshiba.
   Veterinary Laboratory Testing Services Global Market Report 2022  2022/05/26 10:18:00 GlobeNewswire
Major players in the veterinary laboratory testing market are ABAXIS, Inc, IDEXX Laboratories, Inc, Heska Corporation, Pfizer Animal Health, Neogen Corporation, Thermo Fisher Scientific Inc, Zoetis, Inc. Major players in the veterinary laboratory testing market are ABAXIS, Inc, IDEXX Laboratories, Inc, Heska Corporation, Pfizer Animal Health, Neogen Corporation, Thermo Fisher Scientific Inc, Zoetis, Inc.
   Investment - $72.21 Million in Sales Expected for Heska Co. This Quarter  2022/05/15 09:57:10 Business Mag
Wall Street analysts forecast that Heska Co. will report $72.21 million in sales for the current fiscal quarter, according to Zacks Investment Research. Four analysts have…
   Analyst Ratings for Heska  2022/05/10 13:16:57 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Heska (NASDAQ: HSKA ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company''s business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 2 2 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 1 1 0 0 In the last 3 months, 4 analysts have offered 12-month price targets for Heska. The company has an average price target of $187.5 with a high of $250.00 and a low of $149.00. Below is a summary of how these 4 analysts … Full story available on Benzinga.com
   Veterinary Healthcare 2022 Global Market Outlook, Research, Trends and Forecast to 2028  2022/05/26 12:49:00 SBWire
Global Veterinary Healthcare Market is valued approximately USD 49119.8 Million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.31% over the forecast period 2022-2028. London, UK -- ( SBWIRE ) -- 05/26/2022 -- A New Market Research Study on "Global Veterinary Healthcare Size & Growth Analysis Report 2022-2028" added on intelligencemarketreport.com with the latest market size, share, trends and regional analysis. Veterinary Healthcare offers treatment for both small and large animals with experienced and professional vet services. The major factors driving the growth for the market are increasing prevalence of zoonotic diseases. For instance, according to the World Health Organization (WHO), there are currently over 200 prevailing zoonosis diseases around the world, including new and existing diseases, as of 2020. According to a UN Food and Agriculture Organization report, the majority of human diseases are spread by animals. Along with this, increasing initiatives by governments and animal welfare associations globally.
   Veterinary Diagnostic Equipment Global Market Report 2022  2022/05/26 10:23:00 GlobeNewswire
Major players in the Veterinary diagnostic equipment market are IDEXX Laboratories, ABAXIS, HESKA Corporation, Zoetis, Virbac, Mindray Medical International Ltd. , Neogen Corporation, QIAGEN N. V. , Agfa Healthcare, and Toshiba. Major players in the Veterinary diagnostic equipment market are IDEXX Laboratories, ABAXIS, HESKA Corporation, Zoetis, Virbac, Mindray Medical International Ltd. , Neogen Corporation, QIAGEN N. V. , Agfa Healthcare, and Toshiba.
   Veterinary Laboratory Testing Services Global Market Report 2022  2022/05/26 10:18:00 GlobeNewswire
Major players in the veterinary laboratory testing market are ABAXIS, Inc, IDEXX Laboratories, Inc, Heska Corporation, Pfizer Animal Health, Neogen Corporation, Thermo Fisher Scientific Inc, Zoetis, Inc. Major players in the veterinary laboratory testing market are ABAXIS, Inc, IDEXX Laboratories, Inc, Heska Corporation, Pfizer Animal Health, Neogen Corporation, Thermo Fisher Scientific Inc, Zoetis, Inc.
   Investment - $72.21 Million in Sales Expected for Heska Co. This Quarter  2022/05/15 09:57:10 Business Mag
Wall Street analysts forecast that Heska Co. will report $72.21 million in sales for the current fiscal quarter, according to Zacks Investment Research. Four analysts have…
   Analyst Ratings for Heska  2022/05/10 13:16:57 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Heska (NASDAQ: HSKA ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company''s business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 2 2 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 1 1 0 0 In the last 3 months, 4 analysts have offered 12-month price targets for Heska. The company has an average price target of $187.5 with a high of $250.00 and a low of $149.00. Below is a summary of how these 4 analysts … Full story available on Benzinga.com
   Heska Corporation''s (HSKA) CEO Kevin Wilson on Q4 2021 Results - Earnings Call Transcript  2022/02/28 19:27:05 Seeking Alpha
   Heska Non-GAAP EPS of $0.35 beats by $0.03, revenue of $68.06M beats by $2.03M  2022/02/28 13:07:37 Seeking Alpha
Heska press release (HSKA): Q4 Non-GAAP EPS of $0.35 beats by $0.03.Revenue of $68.06M (+5.8% Y/Y) beats by $2.03M.2022 Outlook: Revenue expected to be in the range of $287M -$297M…
   Heska Corporation Reports Fourth Quarter and Full Year 2021 Results  2022/02/28 13:00:00 PR Newswire
LOVELAND, Colo., Feb. 28, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments (North America and International) for its fourth quarter…
   Earnings Scheduled For February 28, 2022  2022/02/28 09:17:09 Benzinga
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ: LXRX ) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (NASDAQ: PRAX ) is likely to report earnings for its fourth quarter. • Blackstone Secured (NYSE: BXSL ) is likely to report quarterly earnings at $0.59 per share on revenue of $171.69 million. • Mersana Therapeutics (NASDAQ: MRSN ) is estimated to report earnings for its fourth quarter. • Partner Communications Co (NASDAQ: PTNR ) is expected to report earnings for its fourth quarter. • Daqo New Energy (NYSE: DQ ) is expected to report quarterly earnings at $4.58 per share on revenue of $698.65 million. • Easterly Government Props (NYSE: DEA ) is likely to report quarterly earnings at $0.10 per share on revenue of $72.20 million. • Aurinia Pharmaceuticals (NASDAQ: AUPH ) is expected to report earnings for its fourth quarter. • Kosmos Energy (NYSE: KOS ) is estimated to report quarterly earnings at $0.15 per share on revenue of $380.
   Heska Corp. (Restricted Voting) Shares Fall 4.1% Below Previous 52-Week Low - Market Mover  2022/01/28 11:03:40 Kwhen Finance
Heska Corp. (Restricted Voting) (HSKA) shares closed 4.1% lower than its previous 52 week low, giving the company a market cap of $1B. The stock is currently down 24.3% year-to-date, down 20.9% over the past 12 months, and up 79.6% over the past five years. This week, the Dow Jones Industrial Average fell 1.6%, and the S&P 500 fell 3.5%. Trading Activity Trading volume this week was 36.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.6. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 152.9% The company's stock price performance over the past 12 months lags the peer average by -370.6% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 229.0% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 ヘスカ HSKA Heska Corporation)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)